Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Asset disposition
Quarterly results
Appointed director
CC transcript

MYLAN INC. (MYL) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/02/2015 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Mylan Fourth Quarter 2014 Adjusted Diluted EPS Increases 35% to $1.05 and Full Year Adjusted Diluted EPS Up 23% to $3.56"
02/27/2015 8-K Form 8-K - Current report
01/30/2015 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Ob...
01/29/2015 8-K Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits
Docs: "Mylan Shareholders Overwhelmingly Approve Agreement Implementing Acquisition of Abbott's Non-U.S. Developed Markets Specialty and Branded Generics Business PITTSBURGH - Jan. 29, 2015 - Mylan Inc. announced that at a Special Meeting of Shareholders held Jan. 29, 2015, Mylan's shareholders overwhelmingly approved the agreement implementing Mylan's pending acquisition of Abbott's non-U.S. developed markets specialty and branded generics business and reorganization in the Netherlands in an all-stock transaction. The agreement implementing the transaction received the approval of approximately 98% of the votes cast and the advisory vote on the proposal regarding certain compensation matters related to the transaction received the approval of approximately 82% of the votes cast. As previously an..."
01/28/2015 8-K Other Events
01/14/2015 8-K Investor presentation
Docs: "J.P. Morgan Healthcare Conference Transcript"
12/29/2014 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Ob...
11/05/2014 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
10/30/2014 8-K Quarterly results
Docs: "Mylan Third Quarter 2014 Adjusted Diluted EPS Increases 41% to $1.16 2014 Adjusted Diluted EPS Guidance Range Increases to $3.54 to $3.60"
10/22/2014 8-K Entry into a Material Definitive Agreement
10/16/2014 8-K Other Events
10/03/2014 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Mylan Increases Third Quarter and Full Year 2014 Adjusted Diluted EPS Guidance Range"
08/07/2014 8-K Quarterly results
Docs: "Mylan Reports Second Quarter 2014 Adjusted Diluted EPS of $0.69, In Line With Guidance Narrows 2014 Adjusted Diluted EPS Guidance Range to $3.25 to $3.45"
08/06/2014 8-K Other Events, Financial Statements and Exhibits Interactive Data
Docs: "Consent of Deloitte & Touche LLP",
"Part II, Item 6. Selected Financial Data; Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations; and Item 8. Financial Statements and Supplementary Data from the 2013 Annual Report, each as revised",
"Part IV, Item 15. Exhibits, Consolidated Financial Statement Schedules, 2. Consolidated Financial Statement Schedules: Schedule II - Valuation and Qualifying Accounts, as revised"
08/01/2014 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
07/14/2014 8-K Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Other Events, Financial Sta...
Docs: "MYLAN TO ACQUIRE ABBOTT'S NON-U.S. DEVELOPED MARKETS SPECIALTY AND BRANDED GENERICS BUSINESS IN AN ALL-STOCK TRANSACTION"
07/03/2014 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Mylan Schedules Second Quarter 2014 Financial Results Conference Call and Live Webcast for Aug. 7, 2014"
05/01/2014 8-K Quarterly results
Docs: "Mylan First Quarter 2014 Adjusted Diluted EPS Increases 6% to $0.66"
04/11/2014 8-K Submission of Matters to a Vote of Security Holders
03/17/2014 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/07/2014 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
02/28/2014 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Third Amended and Restated Executive Employment Agreement, entered into on February 25, 2014, by and between Mylan Inc. and Robert J. Coury",
"Amendment No. 6 to Retirement Benefit Agreement by and between Mylan Inc. and Robert J. Coury",
"Second Amended and Restated Executive Employment Agreement, entered into on February 25, 2014, by and between Mylan Inc. and Heather Bresch",
"Second Amended and Restated Executive Employment Agreement, entered into on February 25, 2014, by and between Mylan Inc. and Rajiv Malik",
"Form of Stock Appreciation Rights Award Agreement under the Mylan Inc. One-Time Special Five-Year Performance-Based Realizable Value Incentive Program",
"Form of Performance-Based Restricted Stock Units Award Agreement under the Mylan Inc. One-Time Special Five-Year Performance-Based Realizable Value Incentive Program",
"Amendment to Amended and Restated 2003 Long-Term Incentive Plan"
02/27/2014 8-K Quarterly results
Docs: "EXHIBIT"
12/05/2013 8-K Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Other Events
11/29/2013 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Indenture, by and between the Company and The Bank of New York Mellon, as trustee",
"First Supplemental Indenture, by and between the Company and The Bank of New York Mellon, as trustee",
"Opinion of Skadden, Arps, Slate, Meagher & Flom LLP",
"Opinion of Bradley L. Wideman",
"Computation of Ratio of Earnings to Fixed Charges"
11/20/2013 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Underwriting Agreement datedNovember 19, 2013by and among the Company, Merrill Lynch, Pierce, Fenner, & Smith Incorporated, J.P. Morgan Securities LLC, and Morgan Stanley & Co. LLC, as representatives of the underwriters named therein",
"EXHIBIT"
10/31/2013 8-K Form 8-K - Current report
08/01/2013 8-K Quarterly results
Docs: "Mylan Reports a 13% Increase in Second Quarter 2013 Adjusted Diluted EPS to $0.68"
06/27/2013 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Ob...
Docs: "Indenture, among the Company, the guarantors named therein and The Bank of New York Mellon, as trustee",
"Registration Rights Agreement, among the Company, the guarantors named therein, and the representatives of the initial purchasers of the Notes",
"Credit Agreement, by and among the Company, the lenders party thereto, and Bank of America, N.A., as administrative agent"
06/18/2013 8-K Other Events, Financial Statements and Exhibits
Docs: "EXHIBIT"
05/02/2013 8-K Quarterly results
Docs: "Mylan Reports a 19% Increase in First Quarter 2013 Adjusted Diluted EPS to $0.62"
10/25/2012 8-K Quarterly results
Docs: "EXHIBIT"
07/26/2012 8-K Form 8-K - Current report
05/04/2012 8-K Submission of Matters to a Vote of Security Holders
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy